Publication

Article

Pharmaceutical Executive

Pharmaceutical Executive-11-28-2007
Volume0
Issue 0

Test

Author(s):

Matthew Herman

TKTKTKTKTKTK

Articles in this issue
Test

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Michael Grosberg
Related Content
MannKind Expands Cardiometabolic and Lung Portfolio with $360 Million Acquisition of scPharmaceuticals
August 26th 2025

MannKind Expands Cardiometabolic and Lung Portfolio with $360 Million Acquisition of scPharmaceuticals

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 26th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 26th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 26th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stock.adobe.com
August 26th 2025

BeOne Medicines Announces $950 Million Royalty Purchase Agreement with Royalty Pharma for Imdelltra

Nicholas Jacobus
Stock.adobe.com
August 26th 2025

Valneva Reveals FDA’s Decision to Suspend Ixchiq’s License in the U.S.

Nicholas Jacobus